Pallas Capital Advisors LLC Raises Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Pallas Capital Advisors LLC grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 222.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 44,865 shares of the medical instruments supplier’s stock after buying an additional 30,953 shares during the period. Pallas Capital Advisors LLC’s holdings in DENTSPLY SIRONA were worth $670,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at $26,000. Colonial Trust Co SC purchased a new stake in DENTSPLY SIRONA during the 4th quarter worth about $26,000. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after purchasing an additional 1,568 shares in the last quarter. True Wealth Design LLC lifted its holdings in DENTSPLY SIRONA by 866.7% during the 4th quarter. True Wealth Design LLC now owns 2,175 shares of the medical instruments supplier’s stock worth $41,000 after purchasing an additional 1,950 shares in the last quarter. Finally, Quarry LP lifted its holdings in DENTSPLY SIRONA by 25.7% during the 4th quarter. Quarry LP now owns 3,816 shares of the medical instruments supplier’s stock worth $72,000 after purchasing an additional 780 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ XRAY opened at $16.11 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The firm has a market capitalization of $3.21 billion, a P/E ratio of -7.78, a P/E/G ratio of 1.80 and a beta of 0.95. The stock’s 50-day simple moving average is $14.73 and its two-hundred day simple moving average is $16.91. DENTSPLY SIRONA Inc. has a twelve month low of $12.16 and a twelve month high of $27.95.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the consensus estimate of $0.29 by $0.14. The firm had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the company earned $0.42 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 annualized dividend and a dividend yield of 3.97%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -14.10%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on XRAY shares. Wall Street Zen raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, May 9th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research increased their price objective on DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an “outperform” rating in a report on Monday, May 12th. UBS Group dropped their price objective on DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a report on Friday, May 9th. Finally, Robert W. Baird dropped their price objective on DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating on the stock in a report on Friday, February 28th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $20.36.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.